Eli Lilly, Junshi Biosciences to start human trials of COVID-19 antibodies

Shanghai Junshi Biosciences Co Ltd said on Tuesday it planned to start clinical studies to test its experimental COVID-19 antibodies, developed with partner Eli Lilly and Co, by the second quarter of the year in the United States and China. Read More

from Canoe https://ift.tt/36Dwo3y